Skip to content
Drug Prices AV Recommends More Clear Disclosures for Medicare Prescription Payment Plan Criminal Justice Why Evidence Matters Medicare Sustainability AV Submits Letter Addressing Overpayments in Medicare Advantage Criminal Justice What a Bipartisan State of the Union Looks Like Op-Ed Same Service, Same Price New Chart Shows State-Level Impacts of Site Neutrality Commercial Sector Prices AV Submits Letter on the Proposed Rule on Operations of the No Surprises Act’s Independent Dispute Resolution Process Health AV Responds to HELP Committee Request for Information on Gene Therapies Complex Care AV Submits Letter on Transparency and Accountability in Medicare Advantage Commercial Sector Prices Paying a Site-Neutral Rate for Off-Campus Outpatient Departments Could Save Billions Drug Prices AV Submits Letter on Controlled Clinical Investigation and Confirmatory Evidence Drug Prices AV Submits Letter on Excise Tax on Designated Drugs

About Us

We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
Arnold Ventures logo